Outcome Reduction With Initial Glargine Intervention - ORIGIN Fatty Acids

Description:

The goal of the trial was to evaluate treatment with n-3 fatty acids compared with placebo among patients at elevated cardiac risk with impaired fasting glucose, impaired glucose tolerance, or diabetes.